US Stock MarketDetailed Quotes

ESLA Estrella Immunopharma

Watchlist
  • 1.010
  • +0.010+1.00%
Close Nov 26 16:00 ET
  • 1.000
  • -0.010-0.99%
Post 16:49 ET
36.54MMarket Cap-4139P/E (TTM)

Estrella Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
80.53%3.38M
-34.23%7.31M
44.59%3.95M
-82.87%469.53K
-62.97%1.02M
-35.17%1.87M
559.47%11.11M
154.29%2.73M
1,528.78%2.74M
2,502.95%2.76M
Selling and administrative expenses
-60.29%550.74K
382.69%3.2M
172.56%424.45K
277.66%444.53K
536.85%945.17K
394.92%1.39M
123.86%663.19K
382.74%155.73K
745.08%117.71K
358.08%148.41K
-General and administrative expense
-60.29%550.74K
382.69%3.2M
172.56%424.45K
277.66%444.53K
536.85%945.17K
394.92%1.39M
123.86%663.19K
382.74%155.73K
745.08%117.71K
358.08%148.41K
Research and development costs
484.53%2.83M
-60.68%4.11M
36.85%3.53M
-99.05%25K
-97.11%75.46K
-81.44%483.47K
652.37%10.45M
147.22%2.58M
1,306.35%2.62M
3,448.49%2.61M
Operating profit
-80.53%-3.38M
34.23%-7.31M
-44.59%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Net non-operating interest income expense
Other net income (expense)
Income before tax
-80.53%-3.38M
34.23%-7.31M
-44.59%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Income tax
0
1.63K
1.63K
0
0
0
0
0
0
0
Net income
-80.53%-3.38M
34.21%-7.31M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Net income continuous Operations
-80.53%-3.38M
34.21%-7.31M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Minority interest income
Net income attributable to the parent company
-80.53%-3.38M
34.21%-7.31M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-80.53%-3.38M
34.21%-7.31M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Basic earnings per share
-69.37%-0.09
14.49%-0.27
-67.53%-0.13
87.16%-0.01
61.69%-0.03
35.18%-0.0531
-559.47%-0.3157
-154.29%-0.0776
-1,528.74%-0.0779
-2,503.13%-0.0783
Diluted earnings per share
-69.37%-0.09
14.49%-0.27
-67.53%-0.13
87.16%-0.01
61.69%-0.03
35.18%-0.0531
-559.47%-0.3157
-154.29%-0.0776
-1,528.74%-0.0779
-2,503.13%-0.0783
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 80.53%3.38M-34.23%7.31M44.59%3.95M-82.87%469.53K-62.97%1.02M-35.17%1.87M559.47%11.11M154.29%2.73M1,528.78%2.74M2,502.95%2.76M
Selling and administrative expenses -60.29%550.74K382.69%3.2M172.56%424.45K277.66%444.53K536.85%945.17K394.92%1.39M123.86%663.19K382.74%155.73K745.08%117.71K358.08%148.41K
-General and administrative expense -60.29%550.74K382.69%3.2M172.56%424.45K277.66%444.53K536.85%945.17K394.92%1.39M123.86%663.19K382.74%155.73K745.08%117.71K358.08%148.41K
Research and development costs 484.53%2.83M-60.68%4.11M36.85%3.53M-99.05%25K-97.11%75.46K-81.44%483.47K652.37%10.45M147.22%2.58M1,306.35%2.62M3,448.49%2.61M
Operating profit -80.53%-3.38M34.23%-7.31M-44.59%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Net non-operating interest income expense
Other net income (expense)
Income before tax -80.53%-3.38M34.23%-7.31M-44.59%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Income tax 01.63K1.63K0000000
Net income -80.53%-3.38M34.21%-7.31M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Net income continuous Operations -80.53%-3.38M34.21%-7.31M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Minority interest income
Net income attributable to the parent company -80.53%-3.38M34.21%-7.31M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -80.53%-3.38M34.21%-7.31M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Basic earnings per share -69.37%-0.0914.49%-0.27-67.53%-0.1387.16%-0.0161.69%-0.0335.18%-0.0531-559.47%-0.3157-154.29%-0.0776-1,528.74%-0.0779-2,503.13%-0.0783
Diluted earnings per share -69.37%-0.0914.49%-0.27-67.53%-0.1387.16%-0.0161.69%-0.0335.18%-0.0531-559.47%-0.3157-154.29%-0.0776-1,528.74%-0.0779-2,503.13%-0.0783
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data